scholarly journals INCIDENCE OF HERPES SIMPLEX VIRUS KERATITIS AND OTHER OCULAR DISEASE: GLOBAL REVIEW AND ESTIMATES

2021 ◽  
pp. 1-10
Author(s):  
Ian McCormick ◽  
Charlotte James ◽  
Nicky J Welton ◽  
Philippe Mayaud ◽  
Katherine M. E Turner ◽  
...  
Intervirology ◽  
1988 ◽  
Vol 29 (1) ◽  
pp. 39-49 ◽  
Author(s):  
Joseph F. Metcalf ◽  
Subhendra Chatterjee ◽  
Junichi Koga ◽  
Richard J. Whitley

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Haya H Al-Ani ◽  
Lucy M Lu ◽  
Jay J Meyer ◽  
Rachael L Niederer

2016 ◽  
Vol 90 (18) ◽  
pp. 8115-8131 ◽  
Author(s):  
Kyubin Lee ◽  
Aaron W. Kolb ◽  
Inna Larsen ◽  
Mark Craven ◽  
Curtis R. Brandt

ABSTRACTHerpes simplex virus 1 (HSV-1) most commonly causes recrudescent labial ulcers; however, it is also the leading cause of infectious blindness in developed countries. Previous research in animal models has demonstrated that the severity of HSV-1 ocular disease is influenced by three main factors: host innate immunity, host immune response, and viral strain. We have previously shown that mixed infection with two avirulent HSV-1 strains (OD4 and CJ994) results in recombinants with a wide range of ocular disease phenotype severity. Recently, we developed a quantitative trait locus (QTL)-based computational approach (vQTLmap) to identify viral single nucleotide polymorphisms (SNPs) predicted to influence the severity of the ocular disease phenotypes. We have now applied vQTLmap to identify HSV-1 SNPs associated with corneal neovascularization and mean peak percentage weight loss (MPWL) using 65 HSV-1 OD4-CJ994 recombinants. The vQTLmap analysis using Random Forest for neovascularization identified phenotypically meaningful nonsynonymous SNPs in the ICP4, UL41 (VHS), UL42, UL46 (VP11/12), UL47 (VP13/14), UL48 (VP22), US3, US4 (gG), US6 (gD), and US7 (gI) coding regions. The ICP4 gene was previously identified as a corneal neovascularization determinant, validating the vQTLmap method. Further analysis detected an epistatic interaction for neovascularization between a segment of the unique long (UL) region and a segment of the inverted repeat short (IRS)/unique short (US) region. Ridge regression was used to identify MPWL-associated nonsynonymous SNPs in the UL1 (gL), UL2, UL4, UL49 (VP22), UL50, and ICP4 coding regions. The data provide additional insights into virulence gene and epistatic interaction discovery in HSV-1.IMPORTANCEHerpes simplex virus 1 (HSV-1) typically causes recurrent cold sores; however, it is also the leading source of infectious blindness in developed countries. Corneal neovascularization is critical for the progression of blinding ocular disease, and weight loss is a measure of infection severity. Previous HSV-1 animal virulence studies have shown that the severity of ocular disease is partially due to the viral strain. In the current study, we used a recently described computational quantitative trait locus (QTL) approach in conjunction with 65 HSV-1 recombinants to identify viral single nucleotide polymorphisms (SNPs) involved in neovascularization and weight loss. Neovascularization SNPs were identified in the ICP4, VHS, UL42, VP11/12, VP13/14, VP22, gG, US3, gD, and gI genes. Further analysis revealed an epistatic interaction between the UL and US regions. MPWL-associated SNPs were detected in the UL1 (gL), UL2, UL4, VP22, UL50, and ICP4 genes. This approach will facilitate future HSV virulence studies.


2011 ◽  
Vol 56 (3) ◽  
pp. 1390-1402 ◽  
Author(s):  
Marianne Berdugo ◽  
Inna V. Larsen ◽  
Claire Abadie ◽  
Catherine Deloche ◽  
Laura Kowalczuk ◽  
...  

ABSTRACTHerpes simplex ocular infection is a major cause of corneal blindness. Local antiviral treatments exist but are associated with corneal toxicity, and resistance has become an issue. We evaluated the biodistribution and efficacy of a humanized anti-herpes simplex virus (anti-HSV) IgG FAb fragment (AC-8; 53 kDa) following repeated topical administration. AC-8 was found in the corneal epithelium, anterior stroma, subepithelial stromal cells, and retinal glial cells, with preferential entry through the ocular limbus. AC-8 was active against 13 different strains of HSV-1, with 50% and 90% mean effective concentrations (MEC50and MEC90, respectively) ranging from 0.03 to 0.13 μg/ml, indicating broad-spectrum activity. Thein vivoefficacy of AC-8 was evaluated in a mouse model of herpes-induced ocular disease. Treatment with low-dose AC-8 (1 mg/ml) slightly reduced the ocular disease scores. A greater reduction of the disease scores was observed in the 10-mg/ml AC-8-treated group, but not as much as with trifluridine (TFT). AC-8 treatment reduced viral titers but less than trifluridine. AC-8 did not display any toxicity to the cornea or other structures in the eye. In summary, topical instillation of an anti-HSV FAb can be used on both intact and ulcerated corneas. It is well tolerated and does not alter reepithelialization. Further studies to improve the antiviral effect are needed for AC-8 to be considered for therapeutic use.


Cornea ◽  
1987 ◽  
Vol 6 (2) ◽  
pp. 158
Author(s):  
R. D. Stulting ◽  
S. Z. Abghari ◽  
R. J. Epstein ◽  
A. J. Nahmias

Sign in / Sign up

Export Citation Format

Share Document